XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Activities      
Net income $ 143,419 $ 155,709 $ 111,783
Loss from discontinued operations, net of income taxes 28,880 21,818 56,447
Income from continuing operations 172,299 177,527 168,230
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations:      
Depreciation and amortization 98,818 104,168 109,596
Impairment of goodwill and intangible assets 36,684 0 0
Impairment, Long-Lived Asset, Held-for-Use 5,480 2,217 397
Incremental charges on purchase accounting valuation of biological assets and inventory 0 0 41,145
Net gain on sale of assets (2,648) (54,108) (11,784)
Gain (Loss) on Disposition of Stock in Subsidiary (76,417) 0 0
Unrealized Gain (Loss) on Investments (12,397) 2,004 7,167
Stock-based compensation expense 7,951 6,045 4,500
Equity method earnings (8,308) (15,191) (6,726)
Amortization of debt discounts and debt issuance costs 7,746 6,390 6,213
Deferred tax benefit (17,588) (12,600) (31,061)
Pension and other postretirement benefit plan expense 5,404 7,735 3,151
Dividends received from equity method investees 7,049 9,388 9,817
Other (247) 47 (400)
Changes in operating assets and liabilities:      
Receivables, net of allowances (20,603) 58,794 55,150
Inventories 70,810 (20,688) 31,685
Prepaids, other current assets and other assets (281) (27,521) (11,073)
Accounts payable, accrued liabilities and other liabilities 130,589 13,022 10,975
Net Cash Provided by (Used in) Operating Activities, Continuing Operations 262,721 298,605 323,612
Investing Activities      
Sales of assets 5,011 83,557 36,676
Capital expenditures (82,435) (78,041) (85,564)
Proceeds from Sales of Business, Affiliate and Productive Assets 117,935    
Proceeds from sale of business, net of transaction costs (926) (1,263) (4,886)
Insurance proceeds 527 1,054 2,278
Purchases of investments (262) (1,153) (458)
(Purchases) sales of unconsolidated affiliates (1,769) 1,013 (3,029)
Other (2,301) 57 912
Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total 35,780 5,224 (54,071)
Financing Activities      
Proceeds from borrowings and overdrafts 1,517,106 1,407,970 1,293,280
Repayments on borrowings and overdrafts (1,696,130) (1,576,067) (1,411,467)
Payment of debt issuance costs 0 (44) (304)
Dividends paid to shareholders (30,551) (30,373) (30,364)
Dividends paid to noncontrolling interests (26,579) (28,522) (21,632)
Other noncontrolling interest activity, net (124) (1,300) 0
Payments of contingent consideration 1,567 1,662 2,909
Net cash used in financing activities - continuing operations (237,845) (229,998) (173,396)
Effect of foreign currency exchange rate changes on cash (15,241) 5,448 (20,712)
Net cash provided by (used in) operating activities - discontinued operations 22,592 (22,622) (84,720)
Net cash used in investing activities - discontinued operations (13,293) (8,492) (12,434)
Cash provided by (used in) discontinued operations, net 9,299 (31,114) (97,154)
Increase (decrease) in cash and cash equivalents 54,714 48,165 (21,721)
Cash and cash equivalents at beginning of period, including discontinued operations 277,005 228,840 250,561
Cash and cash equivalents at end of period, including discontinued operations 331,719 277,005 228,840
Supplemental cash flow information:      
Income tax payments, net of refunds (77,967) (63,969) (50,469)
Interest payments on borrowings (67,397) (82,367) (53,404)
Non-cash Investing and Financing Activities:      
Accrued property, plant and equipment $ (2,983) $ (1,465) $ (488)